These results indicated that daphnetin protects diabetes cognitive dysfunction by regulating GLP-1R-mediated inflammation and oxidative stress, act as a GLP-1R agonist
Niemyjska-Dmoch, W., Kosiski, P., Wgrzyn, P., Luterek, K
Gastroenterology 123, 531541
Patients with genetic slow-metabolizer phenotypes, liver disease, or chronic illness may warrant baseline and periodic testing
Yet practical protocols use milligram doses, thousands of times higher
Most patients see meaningful improvement after completing 3 cycles, roughly three months of consistent treatment